Search type: go_term
Results for query: angiogenesis
| Gene Symbol | Gene Name | Links to Senescence |
|---|---|---|
| ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase |
U: 1
|
| ACVR1 | activin A receptor, type 1 |
U: 1
|
| ACVR2B | activin receptor IIB |
U: 1
D: 1
|
| ADAM12 | a disintegrin and metallopeptidase domain 12 (meltrin alpha) |
U: 1
D: 1
|
| ADAM15 | a disintegrin and metallopeptidase domain 15 (metargidin) |
U: 1
|
| ADAM8 | a disintegrin and metallopeptidase domain 8 |
D: 1
|
| ADAMTS1 | a disintegrin-like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 1 |
U: 1
D: 3
|
| ADGRA2 | adhesion G protein-coupled receptor A2 |
U: 1
D: 1
|
| ADGRB2 | adhesion G protein-coupled receptor B2 |
U: 2
|
| ADGRB3 | adhesion G protein-coupled receptor B3 |
D: 1
|
| ADGRG1 | adhesion G protein-coupled receptor G1 |
U: 3
D: 1
|
| ADM | adrenomedullin |
U: 4
D: 2
|
| ADM2 | adrenomedullin 2 |
U: 4
D: 1
|
| ADTRP | androgen dependent TFPI regulating protein |
U: 3
D: 1
|
| AGO1 | argonaute RISC catalytic subunit 1 |
D: 1
|
| AGO2 | argonaute RISC catalytic subunit 2 |
U: 1
D: 3
|
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
U: 4
D: 1
|
| AGTR1 | angiotensin II receptor type 1 |
U: 6
D: 2
|
| AIMP1 | aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
D: 1
|
| AKT1 | thymoma viral proto-oncogene 1 |
U: 21
D: 24
|
| AKT3 | thymoma viral proto-oncogene 3 |
D: 1
|
| ALOX5 | arachidonate 5-lipoxygenase |
U: 2
|
| AMOT | angiomotin |
U: 2
|
| AMOTL1 | angiomotin-like 1 |
U: 2
D: 1
|
| AMOTL2 | angiomotin-like 2 |
D: 1
|
| ANG | angiogenin, ribonuclease, RNase A family, 5 |
U: 2
D: 1
|
| ANGPT1 | angiopoietin 1 |
U: 3
D: 3
|
| ANGPT2 | angiopoietin 2 |
U: 3
|
| ANGPT4 | angiopoietin 4 |
U: 1
|
| ANGPTL2 | angiopoietin-like 2 |
U: 3
D: 1
|
| ANGPTL4 | angiopoietin like 4 |
U: 7
D: 1
|
| ANGPTL6 | angiopoietin-like 6 |
U: 1
|
| ANGPTL7 | angiopoietin-like 7 |
U: 1
D: 1
|
| ANPEP | alanyl (membrane) aminopeptidase |
U: 1
D: 2
|
| ANXA1 | annexin A1 |
U: 2
D: 1
|
| ANXA2 | annexin A2 |
U: 1
D: 1
|
| ANXA3 | annexin A3 |
U: 5
D: 3
|
| APLN | apelin |
U: 1
D: 3
|
| APOD | apolipoprotein D |
U: 3
D: 1
|
| APOLD1 | apolipoprotein L domain containing 1 |
D: 3
|
| AQP1 | aquaporin 1 |
U: 2
D: 3
|
| ARHGAP22 | Rho GTPase activating protein 22 |
U: 1
|
| ARHGAP24 | Rho GTPase activating protein 24 |
U: 3
|
| ATF2 | activating transcription factor 2 |
D: 1
|
| ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 |
U: 4
|
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
D: 1
|
| ACE | angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 |
U: 3
|
| ADD1 | adducin 1 (alpha) |
U: 1
|
| ADRB2 | adrenergic receptor, beta 2 |
U: 1
D: 1
|
| B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
U: 2
|
| BCAS3 | breast carcinoma amplified sequence 3 |
U: 2
D: 1
|
| BMP4 | bone morphogenetic protein 4 |
U: 5
D: 1
|
| BMPER | BMP-binding endothelial regulator |
U: 1
|
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) |
U: 1
|
| BRCA1 | breast cancer 1, early onset |
U: 2
D: 10
|
| BECN1 | beclin 1, autophagy related |
U: 6
D: 8
|
| C1GALT1 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 |
U: 1
|
| C3 | complement C3 |
U: 9
D: 1
|
| C3AR1 | complement component 3a receptor 1 |
U: 1
|
| C5AR1 | complement component 5a receptor 1 |
U: 2
D: 1
|
| CALCRL | calcitonin receptor-like |
D: 3
|
| CARD10 | caspase recruitment domain family, member 10 |
U: 1
D: 1
|
| CAV1 | caveolin 1, caveolae protein |
U: 15
D: 7
|
| CCBE1 | collagen and calcium binding EGF domains 1 |
D: 2
|
| CCL11 | chemokine (C-C motif) ligand 11 |
U: 5
D: 1
|
| CCL2 | chemokine (C-C motif) ligand 2 |
U: 39
D: 6
|
| CCN1 | cellular communication network factor 1 |
U: 4
D: 2
|
| CCN2 | cellular communication network factor 2 |
U: 2
D: 3
|
| CCN3 | cellular communication network factor 3 |
U: 1
|
| CD34 | CD34 antigen |
U: 2
D: 3
|
| CD40 | CD40 antigen |
U: 1
|
| CDC42 | cell division cycle 42 |
U: 3
|
| CDH13 | cadherin 13 |
D: 1
|
| CDH5 | cadherin 5 |
U: 1
D: 3
|
| CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 |
U: 2
|
| CELA1 | chymotrypsin-like elastase family, member 1 |
U: 1
|
| CEMIP2 | cell migration inducing hyaluronidase 2 | |
| CHI3L1 | chitinase 3 like 1 |
U: 4
|
| CHRNA7 | cholinergic receptor, nicotinic, alpha polypeptide 7 |
U: 2
D: 1
|
| CIB1 | calcium and integrin binding 1 (calmyrin) |
D: 1
|
| CLDN5 | claudin 5 |
U: 1
D: 2
|
| CLEC14A | C-type lectin domain family 14, member a |
D: 3
|
| CLIC4 | chloride intracellular channel 4 (mitochondrial) |
U: 1
|
| CNMD | chondromodulin | |
| COL15A1 | collagen, type XV, alpha 1 |
U: 3
|
| COL18A1 | collagen, type XVIII, alpha 1 |
U: 2
D: 1
|
| COL22A1 | collagen, type XXII, alpha 1 |
U: 2
|
| COL4A2 | collagen, type IV, alpha 2 |
U: 3
D: 1
|
| COL8A1 | collagen, type VIII, alpha 1 |
U: 2
D: 4
|
| COL8A2 | collagen, type VIII, alpha 2 |
U: 3
|
| CREB3L1 | cAMP responsive element binding protein 3-like 1 |
U: 2
|
| CSPG4 | chondroitin sulfate proteoglycan 4 |
U: 5
D: 1
|
| CTNNB1 | catenin (cadherin associated protein), beta 1 |
U: 7
D: 2
|
| CTSH | cathepsin H |
U: 3
|
| CX3CL1 | chemokine (C-X3-C motif) ligand 1 |
U: 4
|
| CXCL10 | chemokine (C-X-C motif) ligand 10 |
U: 11
|
| CXCL13 | C-X-C motif chemokine ligand 13 |
U: 2
|
| CXCL8 | C-X-C motif chemokine ligand 8 |
U: 49
D: 11
|
| CXCR2 | chemokine (C-X-C motif) receptor 2 |
U: 5
|
| CXCR3 | chemokine (C-X-C motif) receptor 3 |
U: 1
|
| CYBB | cytochrome b-245, beta polypeptide |
U: 3
D: 1
|
| CYP1B1 | cytochrome P450, family 1, subfamily b, polypeptide 1 |
U: 5
D: 1
|
| CAMP | cathelicidin antimicrobial peptide |
U: 1
D: 1
|
| CASP8 | caspase 8 |
U: 1
D: 2
|
| CCL5 | chemokine (C-C motif) ligand 5 |
U: 13
D: 1
|
| CD36 | CD36 molecule |
U: 4
D: 2
|
| CFH | complement component factor h |
U: 3
D: 3
|
| COL24A1 | collagen, type XXIV, alpha 1 |
U: 3
|
| COL4A1 | collagen, type IV, alpha 1 |
U: 3
D: 1
|
| CYSLTR1 | cysteinyl leukotriene receptor 1 |
D: 1
|
| CYSLTR2 | cysteinyl leukotriene receptor 2 |
D: 1
|
| DAB2IP | disabled 2 interacting protein |
U: 1
D: 1
|
| DAG1 | dystroglycan 1 |
U: 1
D: 1
|
| DCN | decorin |
U: 2
D: 2
|
| DDAH1 | dimethylarginine dimethylaminohydrolase 1 |
U: 3
D: 3
|
| DLL1 | delta like canonical Notch ligand 1 |
U: 1
D: 2
|
| DLL4 | delta like canonical Notch ligand 4 |
U: 1
D: 2
|
| DYSF | dysferlin |
U: 3
D: 2
|
| DICER1 | dicer 1, ribonuclease type III |
D: 6
|
| E2F2 | E2F transcription factor 2 |
U: 3
D: 6
|
| E2F7 | E2F transcription factor 7 |
U: 4
D: 3
|
| E2F8 | E2F transcription factor 8 |
D: 2
|
| ECM1 | extracellular matrix protein 1 |
U: 4
|
| ECSCR | endothelial cell surface expressed chemotaxis and apoptosis regulator |
D: 1
|
| EFNA1 | ephrin A1 |
U: 2
|
| EFNA3 | ephrin A3 |
U: 1
|
| EFNB2 | ephrin B2 |
U: 1
D: 1
|
| EGF | epidermal growth factor |
U: 4
D: 5
|
| EGFL7 | EGF-like domain 7 |
U: 1
D: 2
|
| EGLN1 | egl-9 family hypoxia-inducible factor 1 |
U: 1
|
| EGR3 | early growth response 3 |
U: 1
D: 1
|
| EIF2AK3 | eukaryotic translation initiation factor 2 alpha kinase 3 |
U: 2
D: 1
|
| ELK3 | ELK3, member of ETS oncogene family |
U: 1
D: 4
|
| EMILIN1 | elastin microfibril interfacer 1 |
U: 1
D: 4
|
| EMP2 | epithelial membrane protein 2 |
U: 3
D: 2
|
| ENG | endoglin |
U: 4
D: 5
|
| ENPP2 | ectonucleotide pyrophosphatase/phosphodiesterase 2 |
U: 4
D: 1
|
| EPAS1 | endothelial PAS domain protein 1 |
U: 4
D: 4
|
| EPGN | epithelial mitogen |
U: 1
D: 1
|
| EPHA2 | Eph receptor A2 |
U: 2
D: 2
|
| EPHB1 | Eph receptor B1 |
D: 3
|
| EPHB2 | Eph receptor B2 |
U: 2
D: 3
|
| EPHB3 | Eph receptor B3 |
U: 2
D: 2
|
| EPHB4 | Eph receptor B4 |
U: 1
D: 1
|
| EPN2 | epsin 2 |
U: 1
|
| ERAP1 | endoplasmic reticulum aminopeptidase 1 |
D: 1
|
| ERBB2 | erb-b2 receptor tyrosine kinase 2 |
U: 9
|
| EREG | epiregulin |
U: 3
D: 3
|
| ESM1 | endothelial cell-specific molecule 1 |
U: 3
D: 1
|
| ETS1 | E26 avian leukemia oncogene 1, 5' domain |
U: 2
D: 2
|
| F3 | coagulation factor III, tissue factor |
U: 2
D: 2
|
| FAP | fibroblast activation protein |
U: 2
|
| FASLG | Fas ligand |
U: 3
|
| FBLN5 | fibulin 5 |
U: 5
D: 3
|
| FBXW7 | F-box and WD-40 domain protein 7 |
U: 1
D: 1
|
| FGF1 | fibroblast growth factor 1 |
U: 3
D: 2
|
| FGF10 | fibroblast growth factor 10 |
D: 1
|
| FGF18 | fibroblast growth factor 18 |
U: 3
|
| FGF2 | fibroblast growth factor 2 |
U: 14
D: 6
|
| FGFR1 | fibroblast growth factor receptor 1 |
U: 2
|
| FGFR2 | fibroblast growth factor receptor 2 |
U: 3
D: 1
|
| FLT1 | FMS-like tyrosine kinase 1 |
U: 4
D: 4
|
| FLT4 | FMS-like tyrosine kinase 4 |
U: 1
|
| FMNL3 | formin-like 3 |
U: 1
|
| FN1 | fibronectin 1 |
U: 9
D: 5
|
| FOXC1 | forkhead box C1 |
U: 2
D: 1
|
| FOXJ2 | forkhead box J2 |
U: 1
D: 2
|
| FOXO4 | forkhead box O4 |
U: 4
|
| FUT1 | fucosyltransferase 1 |
D: 1
|
| FZD5 | frizzled class receptor 5 |
U: 2
D: 1
|
| FZD8 | frizzled class receptor 8 |
U: 2
D: 2
|
| FLCN | folliculin |
U: 1
|
| FLNA | filamin, alpha |
U: 1
D: 3
|
| GAB1 | growth factor receptor bound protein 2-associated protein 1 |
D: 2
|
| GADD45A | growth arrest and DNA-damage-inducible 45 alpha |
U: 7
D: 1
|
| GATA4 | GATA binding protein 4 |
U: 5
|
| GATA6 | GATA binding protein 6 |
U: 4
D: 1
|
| GJA5 | gap junction protein alpha 5 |
U: 1
|
| GLUL | glutamate-ammonia ligase (glutamine synthetase) |
U: 2
D: 3
|
| GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 |
U: 2
|
| GPNMB | glycoprotein nmb |
U: 5
|
| GPX1 | glutathione peroxidase 1 |
U: 4
D: 7
|
| GRN | granulin |
U: 3
D: 1
|
| GTF2I | general transcription factor II I |
U: 1
D: 1
|
| GNA13 | guanine nucleotide binding protein, alpha 13 |
U: 2
|
| HDAC5 | histone deacetylase 5 |
U: 2
D: 1
|
| HDAC7 | histone deacetylase 7 |
D: 1
|
| HDAC9 | histone deacetylase 9 |
U: 1
D: 2
|
| HEY1 | hes related family bHLH transcription factor with YRPW motif 1 |
U: 1
D: 4
|
| HGF | hepatocyte growth factor |
U: 4
D: 2
|
| HGS | HGF-regulated tyrosine kinase substrate |
U: 1
|
| HHEX | hematopoietically expressed homeobox |
U: 3
D: 2
|
| HIF1A | hypoxia inducible factor 1, alpha subunit |
U: 4
D: 8
|
| HIF3A | hypoxia inducible factor 3, alpha subunit |
U: 1
D: 1
|
| HIPK1 | homeodomain interacting protein kinase 1 |
U: 1
|
| HIPK2 | homeodomain interacting protein kinase 2 |
U: 2
|
| HK2 | hexokinase 2 |
U: 1
D: 3
|
| HLA-G | major histocompatibility complex, class I, G |
U: 1
|
| HMGA2 | high mobility group AT-hook 2 |
U: 3
D: 2
|
| HMOX1 | heme oxygenase 1 |
U: 5
D: 6
|
| HOXA3 | homeobox A3 |
U: 1
D: 1
|
| HOXA5 | homeobox A5 |
D: 1
|
| HOXA7 | homeobox A7 |
D: 1
|
| HOXB3 | homeobox B3 |
D: 1
|
| HPSE | heparanase |
U: 3
|
| HS6ST1 | heparan sulfate 6-O-sulfotransferase 1 |
U: 2
D: 1
|
| HSPB1 | heat shock protein 1 |
U: 4
D: 3
|
| HSPB6 | heat shock protein, alpha-crystallin-related, B6 |
U: 1
|
| HSPG2 | perlecan (heparan sulfate proteoglycan 2) |
U: 3
D: 1
|
| HTATIP2 | HIV-1 Tat interactive protein 2 |
U: 1
|
| HYAL1 | hyaluronoglucosaminidase 1 |
U: 1
|
| HBEGF | heparin-binding EGF-like growth factor |
U: 3
D: 3
|
| HHIP | Hedgehog-interacting protein |
D: 1
|
| HMGB1 | high mobility group box 1 |
U: 5
D: 8
|
| ID1 | inhibitor of DNA binding 1, HLH protein |
U: 1
D: 20
|
| IL10 | interleukin 10 |
U: 4
D: 3
|
| IL12A | interleukin 12a |
U: 5
|
| IL18 | interleukin 18 |
U: 8
D: 1
|
| IL1A | interleukin 1 alpha |
U: 31
D: 6
|
| IL1B | interleukin 1 beta |
U: 48
D: 9
|
| IL6 | interleukin 6 |
U: 97
D: 20
|
| ISM1 | isthmin 1, angiogenesis inhibitor |
U: 1
|
| ITGA5 | integrin alpha 5 (fibronectin receptor alpha) |
U: 3
D: 2
|
| ITGAV | integrin alpha V |
U: 2
D: 1
|
| ITGAX | integrin alpha X |
U: 2
|
| ITGB1 | integrin beta 1 (fibronectin receptor beta) |
U: 3
D: 1
|
| ITGB3 | integrin beta 3 |
U: 5
D: 2
|
| ITGB8 | integrin beta 8 |
U: 3
D: 2
|
| IGF2 | insulin-like growth factor 2 |
U: 3
D: 2
|
| JAG1 | jagged canonical Notch ligand 1 |
U: 3
D: 6
|
| JAK1 | Janus kinase 1 |
U: 3
D: 1
|
| JCAD | junctional cadherin 5 associated |
U: 2
|
| JUN | jun proto-oncogene |
U: 4
D: 7
|
| JUP | junction plakoglobin |
U: 2
|
| KDR | kinase insert domain protein receptor |
U: 2
D: 5
|
| KLF2 | Kruppel-like factor 2 (lung) |
U: 2
D: 5
|
| KLF4 | Kruppel-like factor 4 (gut) |
U: 3
D: 7
|
| KLF5 | Kruppel-like factor 5 |
D: 1
|
| KLK3 | kallikrein related peptidase 3 |
U: 3
|
| KRIT1 | KRIT1, ankyrin repeat containing |
D: 1
|
| KRT1 | keratin 1 |
U: 1
|
| KCTD10 | potassium channel tetramerisation domain containing 10 |
U: 1
|
| LEF1 | lymphoid enhancer binding factor 1 |
U: 1
|
| LEP | leptin |
U: 3
D: 1
|
| LEPR | leptin receptor |
U: 3
D: 1
|
| LOXL2 | lysyl oxidase-like 2 |
U: 4
D: 3
|
| LEMD3 | LEM domain containing 3 |
U: 1
|
| LGALS3 | lectin, galactose binding, soluble 3 |
U: 1
D: 2
|
| LIF | leukemia inhibitory factor |
U: 6
D: 3
|
| MAP3K3 | mitogen-activated protein kinase kinase kinase 3 |
U: 1
D: 2
|
| MAPK14 | mitogen-activated protein kinase 14 |
U: 44
D: 6
|
| MAPK7 | mitogen-activated protein kinase 7 |
D: 1
|
| MCAM | melanoma cell adhesion molecule |
U: 3
D: 2
|
| MECP2 | methyl CpG binding protein 2 |
U: 2
D: 3
|
| MEIS1 | Meis homeobox 1 |
D: 1
|
| MEOX2 | mesenchyme homeobox 2 |
U: 3
D: 1
|
| MFGE8 | milk fat globule-EGF factor 8 protein |
U: 2
|
| MIR106B | microRNA 106b |
U: 2
D: 1
|
| MIR10A | microRNA 10a |
U: 1
|
| MIR10B | microRNA 10b |
U: 1
|
| MIR125A | microRNA 125a |
U: 1
|
| MIR125B1 | microRNA 125b-1 |
U: 1
D: 1
|
| MIR126 | microRNA 126 |
U: 1
D: 2
|
| MIR137 | microRNA 137 |
U: 1
|
| MIR138-1 | microRNA 138-1 |
U: 1
|
| MIR143 | microRNA 143 |
U: 1
|
| MIR145 | microRNA 145 |
U: 1
|
| MIR146A | microRNA 146a |
U: 2
D: 5
|
| MIR149 | microRNA 149 |
U: 1
|
| MIR15B | microRNA 15b | |
| MIR16-1 | microRNA 16-1 |
U: 1
|
| MIR17 | microRNA 17 |
D: 1
|
| MIR181B1 | microRNA 181b-1 |
U: 1
|
| MIR188 | microRNA 188 |
U: 1
|
| MIR18A | microRNA 18a |
U: 1
D: 2
|
| MIR1908 | microRNA 1908 |
D: 1
|
| MIR199A1 | microRNA 199a-1 |
U: 1
|
| MIR19B1 | microRNA 19b-1 |
U: 1
|
| MIR20A | microRNA 20a | |
| MIR21 | microRNA 21 |
U: 2
D: 1
|
| MIR214 | microRNA 214 |
D: 1
|
| MIR217 | microRNA 217 |
U: 2
|
| MIR22 | microRNA 22 |
U: 8
|
| MIR221 | microRNA 221 |
D: 1
|
| MIR222 | microRNA 222 |
U: 1
|
| MIR23A | microRNA 23a |
U: 4
|
| MIR24-1 | microRNA 24-1 |
U: 1
|
| MIR24-2 | microRNA 24-2 | |
| MIR27B | microRNA 27b |
U: 4
|
| MIR29A | microRNA 29a |
U: 3
|
| MIR29C | microRNA 29c |
U: 2
D: 1
|
| MIR30A | microRNA 30a |
U: 1
|
| MIR30E | microRNA 30e |
D: 1
|
| MIR31 | microRNA 31 |
U: 1
D: 1
|
| MIR320A | microRNA 320a |
U: 1
|
| MIR34A | microRNA 34a |
U: 7
D: 2
|
| MIR34B | microRNA 34b |
U: 1
|
| MIR34C | microRNA 34c |
U: 2
|
| MIR410 | microRNA 410 |
D: 1
|
| MIR492 | microRNA 492 |
U: 1
|
| MIR99B | microRNA 99b |
U: 1
|
| MMP14 | matrix metallopeptidase 14 |
U: 7
D: 5
|
| MMP19 | matrix metallopeptidase 19 |
D: 1
|
| MMP2 | matrix metallopeptidase 2 |
U: 12
D: 2
|
| MMRN2 | multimerin 2 |
U: 2
D: 2
|
| MTDH | metadherin |
U: 1
D: 1
|
| MYDGF | myeloid derived growth factor |
U: 1
D: 1
|
| MYH9 | myosin, heavy polypeptide 9, non-muscle |
U: 3
D: 2
|
| MAP3K7 | mitogen-activated protein kinase kinase kinase 7 |
U: 2
|
| MIR23B | microRNA 23b |
U: 1
|
| MMP9 | matrix metallopeptidase 9 |
U: 14
D: 3
|
| NAA15 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit |
D: 2
|
| NAXE | NAD(P)HX epimerase |
D: 1
|
| NCL | nucleolin |
D: 1
|
| NDNF | neuron-derived neurotrophic factor |
U: 1
D: 1
|
| NF1 | neurofibromin 1 |
U: 2
D: 2
|
| NFE2L2 | nuclear factor, erythroid derived 2, like 2 |
U: 4
D: 16
|
| NGFR | nerve growth factor receptor (TNFR superfamily, member 16) |
U: 2
|
| NIBAN2 | niban apoptosis regulator 2 | |
| NOS3 | nitric oxide synthase 3, endothelial cell |
U: 5
D: 13
|
| NOTCH1 | notch 1 |
U: 8
D: 5
|
| NOX1 | NADPH oxidase 1 |
U: 6
|
| NOX5 | NADPH oxidase 5 |
U: 1
|
| NPPB | natriuretic peptide B |
U: 1
|
| NR2E1 | nuclear receptor subfamily 2, group E, member 1 |
D: 3
|
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 |
U: 2
|
| NRARP | Notch-regulated ankyrin repeat protein |
U: 2
D: 2
|
| NRCAM | neuronal cell adhesion molecule |
U: 3
|
| NRP1 | neuropilin 1 |
U: 2
D: 3
|
| NRP2 | neuropilin 2 |
U: 2
D: 1
|
| NFATC1 | nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 1 |
D: 3
|
| NRAS | neuroblastoma ras oncogene |
U: 7
|
| NRXN1 | neurexin I |
U: 1
|
| NRXN3 | neurexin III |
U: 1
|
| PAK4 | p21 (RAC1) activated kinase 4 |
U: 1
D: 2
|
| PARVA | parvin, alpha |
D: 2
|
| PDCD10 | programmed cell death 10 |
U: 2
|
| PDCD6 | programmed cell death 6 |
U: 1
D: 1
|
| PDCL3 | phosducin-like 3 |
D: 1
|
| PDE3B | phosphodiesterase 3B, cGMP-inhibited |
D: 1
|
| PDGFA | platelet derived growth factor, alpha |
U: 3
|
| PDGFRB | platelet derived growth factor receptor, beta polypeptide |
D: 4
|
| PDPK1 | 3-phosphoinositide dependent protein kinase 1 |
U: 2
|
| PDPN | podoplanin |
U: 1
|
| PECAM1 | platelet/endothelial cell adhesion molecule 1 |
U: 2
D: 6
|
| PF4 | platelet factor 4 |
U: 3
D: 1
|
| PGF | placental growth factor |
U: 1
D: 3
|
| PGK1 | phosphoglycerate kinase 1 |
U: 1
|
| PIK3C2A | phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha |
U: 1
D: 2
|
| PIK3CA | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha |
U: 5
D: 5
|
| PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma |
U: 2
D: 3
|
| PIK3R3 | phosphoinositide-3-kinase regulatory subunit 3 |
U: 2
|
| PKM | pyruvate kinase, muscle |
U: 2
D: 1
|
| PLCD1 | phospholipase C, delta 1 |
U: 2
|
| PLCD3 | phospholipase C, delta 3 |
U: 2
|
| PLCG1 | phospholipase C, gamma 1 |
U: 2
D: 1
|
| PLK2 | polo like kinase 2 |
U: 2
D: 1
|
| PLXDC1 | plexin domain containing 1 |
D: 1
|
| PLXND1 | plexin D1 |
U: 1
D: 2
|
| PML | promyelocytic leukemia |
U: 15
D: 2
|
| POFUT1 | protein O-fucosyltransferase 1 |
U: 1
|
| PPARG | peroxisome proliferator activated receptor gamma |
U: 7
D: 9
|
| PPP3CB | protein phosphatase 3, catalytic subunit, beta isoform |
U: 1
D: 1
|
| PRCP | prolylcarboxypeptidase (angiotensinase C) |
U: 1
D: 1
|
| PRKCA | protein kinase C, alpha |
U: 3
D: 3
|
| PRKD1 | protein kinase D1 |
U: 2
D: 1
|
| PRKD2 | protein kinase D2 |
U: 1
D: 1
|
| PRKX | protein kinase, X-linked |
U: 1
D: 1
|
| PRL | prolactin |
U: 1
|
| PROX1 | prospero homeobox 1 |
U: 2
|
| PTEN | phosphatase and tensin homolog |
U: 6
D: 20
|
| PTGIS | prostaglandin I2 (prostacyclin) synthase |
U: 2
D: 2
|
| PTGS2 | prostaglandin-endoperoxide synthase 2 |
U: 12
D: 4
|
| PTK2 | PTK2 protein tyrosine kinase 2 |
U: 1
D: 4
|
| PTK2B | PTK2 protein tyrosine kinase 2 beta |
U: 1
|
| PTN | pleiotrophin |
U: 2
D: 6
|
| PTPN14 | protein tyrosine phosphatase, non-receptor type 14 |
U: 1
|
| PTPRB | protein tyrosine phosphatase, receptor type, B |
U: 2
D: 2
|
| PTPRM | protein tyrosine phosphatase, receptor type, M |
U: 3
|
| PIK3CB | phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta |
U: 2
|
| PLAU | plasminogen activator, urokinase |
U: 7
|
| PNPLA6 | patatin-like phospholipase domain containing 6 |
U: 1
|
| PXN | paxillin |
U: 1
D: 2
|
| RAMP1 | receptor (calcitonin) activity modifying protein 1 |
U: 4
D: 2
|
| RAMP2 | receptor (calcitonin) activity modifying protein 2 |
D: 2
|
| RAPGEF3 | Rap guanine nucleotide exchange factor (GEF) 3 |
U: 1
D: 4
|
| RBPJ | recombination signal binding protein for immunoglobulin kappa J region |
D: 2
|
| RECK | reversion-inducing-cysteine-rich protein with kazal motifs |
U: 1
D: 1
|
| RGCC | regulator of cell cycle |
U: 1
D: 4
|
| RHOA | ras homolog family member A |
U: 3
|
| RHOB | ras homolog family member B |
U: 3
D: 4
|
| RHOJ | ras homolog family member J |
U: 2
|
| RNF213 | ring finger protein 213 |
U: 4
D: 1
|
| RNH1 | ribonuclease/angiogenin inhibitor 1 |
U: 2
|
| ROBO1 | roundabout guidance receptor 1 |
D: 2
|
| ROBO4 | roundabout guidance receptor 4 |
U: 1
D: 1
|
| ROCK1 | Rho-associated coiled-coil containing protein kinase 1 |
D: 1
|
| ROCK2 | Rho-associated coiled-coil containing protein kinase 2 |
D: 2
|
| RORA | RAR-related orphan receptor alpha |
U: 5
|
| RRAS | related RAS viral (r-ras) oncogene |
U: 3
D: 2
|
| RSPO3 | R-spondin 3 |
U: 2
|
| RUNX1 | runt related transcription factor 1 |
U: 4
D: 1
|
| RXRA | retinoid X receptor alpha |
U: 1
D: 3
|
| S100A1 | S100 calcium binding protein A1 |
U: 1
|
| S100A7 | S100 calcium binding protein A7 |
D: 1
|
| S1PR1 | sphingosine-1-phosphate receptor 1 |
D: 5
|
| SASH1 | SAM and SH3 domain containing 1 |
U: 1
D: 1
|
| SAT1 | spermidine/spermine N1-acetyltransferase 1 |
U: 6
D: 1
|
| SCG2 | secretogranin II |
U: 1
|
| SEMA3E | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E |
U: 2
|
| SEMA4A | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
D: 2
|
| SEMA5A | sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
U: 1
D: 1
|
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A |
U: 1
D: 2
|
| SERPINE1 | serine (or cysteine) peptidase inhibitor, clade E, member 1 |
U: 38
D: 5
|
| SERPINF1 | serine (or cysteine) peptidase inhibitor, clade F, member 1 |
U: 5
D: 3
|
| SETD2 | SET domain containing 2 |
U: 1
D: 1
|
| SFRP1 | secreted frizzled related protein 1 |
U: 2
D: 1
|
| SFRP2 | secreted frizzled-related protein 2 |
U: 2
D: 2
|
| SH2D2A | SH2 domain containing 2A |
U: 2
D: 1
|
| SHB | src homology 2 domain-containing transforming protein B |
U: 1
D: 3
|
| SHC1 | src homology 2 domain-containing transforming protein C1 |
U: 7
D: 1
|
| SIRT1 | sirtuin 1 |
U: 12
D: 110
|
| SLC12A6 | solute carrier family 12 member 6 |
U: 1
|
| SLIT2 | slit guidance ligand 2 |
U: 1
D: 1
|
| SMAD1 | SMAD family member 1 |
U: 1
D: 1
|
| SOX17 | SRY (sex determining region Y)-box 17 |
U: 2
D: 1
|
| SOX18 | SRY (sex determining region Y)-box 18 |
U: 2
D: 1
|
| SP1 | trans-acting transcription factor 1 |
U: 1
D: 2
|
| SP100 | SP100 nuclear antigen |
U: 2
|
| SPARC | secreted acidic cysteine rich glycoprotein |
U: 4
D: 3
|
| SPHK1 | sphingosine kinase 1 |
U: 3
D: 2
|
| SPINK5 | serine peptidase inhibitor Kazal type 5 |
U: 1
|
| SPRED1 | sprouty protein with EVH-1 domain 1, related sequence |
U: 1
D: 3
|
| SPRY2 | sprouty RTK signaling antagonist 2 |
D: 4
|
| SRF | serum response factor |
U: 2
D: 3
|
| SRPK2 | serine/arginine-rich protein specific kinase 2 |
U: 1
|
| SRPX2 | sushi-repeat-containing protein, X-linked 2 |
U: 6
D: 2
|
| STAB1 | stabilin 1 |
D: 1
|
| STARD13 | StAR-related lipid transfer (START) domain containing 13 |
U: 1
|
| STAT1 | signal transducer and activator of transcription 1 |
U: 12
D: 1
|
| STAT3 | signal transducer and activator of transcription 3 |
U: 18
D: 6
|
| STIM1 | stromal interaction molecule 1 |
U: 1
D: 2
|
| SULF1 | sulfatase 1 |
U: 2
D: 2
|
| SYK | spleen tyrosine kinase |
U: 3
D: 2
|
| SARS | seryl-aminoacyl-tRNA synthetase |
U: 1
D: 1
|
| SHH | sonic hedgehog |
U: 2
D: 1
|
| SMAD5 | SMAD family member 5 |
U: 1
D: 2
|
| TAL1 | T cell acute lymphocytic leukemia 1 |
U: 1
D: 1
|
| TBXA2R | thromboxane A2 receptor |
U: 1
D: 1
|
| TEK | TEK receptor tyrosine kinase |
D: 3
|
| TERT | telomerase reverse transcriptase |
U: 6
D: 60
|
| TGFB2 | transforming growth factor, beta 2 |
U: 5
D: 1
|
| TGFBI | transforming growth factor beta induced |
U: 3
D: 1
|
| TGFBR1 | transforming growth factor, beta receptor I |
U: 5
|
| TGFBR2 | transforming growth factor, beta receptor II |
U: 4
D: 2
|
| TGFBR3 | transforming growth factor, beta receptor III |
U: 3
D: 2
|
| TGFBR3L | transforming growth factor, beta receptor III-like |
U: 1
|
| THBS1 | thrombospondin 1 |
U: 7
D: 4
|
| THBS2 | thrombospondin 2 |
U: 4
D: 1
|
| THBS4 | thrombospondin 4 |
D: 4
|
| THSD7A | thrombospondin, type I, domain containing 7A |
U: 2
D: 1
|
| THY1 | thymus cell antigen 1, theta |
U: 2
D: 1
|
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
U: 2
|
| TJP1 | tight junction protein 1 |
D: 1
|
| TLR3 | toll-like receptor 3 |
U: 4
D: 1
|
| TMEM100 | transmembrane protein 100 |
D: 2
|
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 |
U: 1
|
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12a |
U: 3
D: 3
|
| TNFSF12 | tumor necrosis factor (ligand) superfamily, member 12 |
U: 1
|
| TNMD | tenomodulin |
D: 1
|
| TSPAN12 | tetraspanin 12 |
D: 1
|
| TWIST1 | twist family bHLH transcription factor 1 |
D: 14
|
| TCF4 | transcription factor 4 |
U: 1
D: 4
|
| TGFA | transforming growth factor alpha |
U: 1
D: 1
|
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1a |
U: 4
D: 2
|
| UNC5B | unc-5 netrin receptor B |
U: 2
|
| UTS2 | urotensin 2 |
U: 1
|
| VASH1 | vasohibin 1 |
U: 3
D: 2
|
| VASH2 | vasohibin 2 |
D: 2
|
| VAV3 | vav 3 oncogene |
U: 3
D: 2
|
| VEGFA | vascular endothelial growth factor A |
U: 10
D: 5
|
| VEGFC | vascular endothelial growth factor C |
D: 1
|
| VEZF1 | vascular endothelial zinc finger 1 |
D: 3
|
| VHL | von Hippel-Lindau tumor suppressor |
D: 2
|
| WASF2 | WAS protein family, member 2 |
D: 3
|
| WNT5A | wingless-type MMTV integration site family, member 5A |
U: 4
|
| WNT7A | wingless-type MMTV integration site family, member 7A |
U: 1
D: 1
|
| WARS | tryptophanyl-tRNA synthetase |
U: 3
D: 2
|
| WNT7B | wingless-type MMTV integration site family, member 7B |
U: 3
D: 3
|
| XBP1 | X-box binding protein 1 |
U: 3
D: 1
|
| YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
U: 1
D: 2
|
| ZC3H12A | zinc finger CCCH type containing 12A |
U: 3
D: 1
|